NASDAQ: RCKT · Biotechnology
Over the past week, Rocket Pharmaceuticals (RCKT) drew 14 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 88% bullish but is far apart: Reddit runs 100% bullish while News sits at just 64%. Wall Street is more cautious, with 7 of 14 analysts rating RCKT a buy.
There is little buzz around RCKT this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 50% buy share sits next to a crowd that ranges from News at 64% to Reddit at 100%. No other tracker puts the two side by side.
Across 14 analysts the consensus is a Buy: 7 buy calls against 2 sell, with an average 12-month price target of $8.50.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Buy.
The crowd runs 38 points hotter than the 50% analyst buy share, retail is ahead of the Street here. The split is inside the crowd: Reddit reads 100% bullish while News sits at 64%, a 36-point spread that single-source trackers miss.
Over the 30-day window, Rocket Pharmaceuticals (RCKT) buzz held subdued around 23.7 while the price drifted down 23.6% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 2.3M shares. Updated Oct 10, 2026. Over the last 7 trading days, RCKT lost 1.2%. Buzz activity in the recent week averaged 34.6 and was variable, swinging between 14.0 and 52.1. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 8 of the 13 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for RCKT and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live RCKT sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Buy (7 / 5 / 2) |
| Crowd bullish (7d) | 88% |
| Avg price target | $8.50 |
| Most bullish source | Reddit, 100% |
| Most bearish source | News, 64% |
| Sentiment spread | 36 pts |
| Mentions (7d) | 14 |
| Market cap | $288.7M |
| EPS · Beta | -$0.17 · 0.5 |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Rocket Pharmaceuticals (RCKT) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 88% bullish across 3 active sources. Those sources contribute 14 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Rocket Pharmaceuticals (RCKT) is fairly quiet with 1 mentions over the last 7 days; the 30-day context spans 2 tracked subreddits. The 7-day tone is 100% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bullish on Rocket Pharmaceuticals (RCKT), averaging 88% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 100% bullish and News at 64%, a 36-point spread. On the professional side, 7 of 14 analysts rate RCKT a buy.
Of the 14 analysts covering Rocket Pharmaceuticals (RCKT), 7 rate it a buy, 5 a hold and 2 a sell, for a buy consensus. The average price target is $8.50. The crowd is the more bullish of the two, averaging 88%.
Rocket Pharmaceuticals (RCKT)'s cross-source average is bullish at 88% bullish. All 3 tracked sources lean bullish. Reddit reads 100% bullish, X reads 100% bullish and news coverage is the most negative at 64% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
The cross-source average is bullish for Rocket Pharmaceuticals (RCKT) at 88% bullish. All 3 tracked sources lean bullish. The most bearish reading is news at 64% bullish. 3-day activity momentum is rising across News. The buy signal carries 93/100 conviction.
News is the dominant discussion channel with 11 mentions (79% of total volume). X contributes 2 mentions and Reddit contributes 1 mention. The cross-source average is bullish at 88% bullish, while news is the only source with rising 3-day activity. All 3 tracked sources lean bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. RCKT's buy signal at 93/100 conviction reflects a bullish cross-source average at 88% bullish. All 3 tracked sources lean bullish. It is a research shortcut, not financial advice.
The RCKT sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key